INTRODUCTION
Luteinizing hormone (LH) has been shown to be the only hormone essential for maintenance of testicular testosterone pr0duction.l LH mediates its effect on testicular steroidogenesis by binding to high affinity receptors in the plasma membrane of Leydig cells. In recent years, numerous investigators have reported that in vivo administration of LH or human chorionic gonadotropin (hCG) results in the reduction of the number of testicular L H receptors1-' accompanied by a decrease in testosterone production 4, 6+ in response to subsequent stimulation by LH or hCG. Studies from our laboratory, however, have demonstrated that changes in LH receptor number may be dissociated from changes in LH-stimulated testosterone production following in vivo treatment with gonadotropins. 1 We observed that only a single high dose of LH, 100 pg or greater, caused a decrease in testicular responsiveness, whereas twice daily injections of L H for six days or longer were accompanied by a time-related increase in in vivo testicular testosterone secretion in response to a subsequent stimulatory dose of LH. The LH-induced loss of testicular LH receptors was similar in rats that received a single high dose of L H and in rats that received twice daily injections. These observations indicate that different modes of in vivo LH treatment have markedly different effects on testicular responsiveness to subsequent LH/hCG stimulation. Interpretation of these results, however, is complicated by the possibility that chronic pituitary hormone treatment may change ( 1 ) sensitivity of the Leydig cells to subsequent L H stimulation, ( 2 ) secretion or clearance rate of testosterone, and/or ( 3 ) total number of Leydig cells. To distinguish among these possibilities, changes in Leydig cell LH receptor concentration and responsiveness to LH were assessed in the same cells after different modes of in vivo hormone treatment.
Using Metrizamide gradient centrifugation to separate dispersed testicular cells, we found evidence for two distinct populations of Leydig cells.* Leydig cells of these two populations contain similar numbers of L H receptor sites but exhibit marked differences in testosterone production in response to in vitro stimulation by hormone or dibutyryl cyclic AMP. These differences are associated with differences in the activities of steroidogenic enzymes associated with the smooth endoplasmic reticulum. Studies of the role of these two populations of Leydig cells in the regulation of testosterone synthesis in response to in vivo and in vitro gonadotropin treatment will be described.
Isolation and Separation of Leydig Cells
A relatively quick method for the separation of interstitial tissue webs from seminiferous tubules of rat testes was developed while searching for a reliable method of obtaining purified Leydig cells.y This method involves a short (5 min) incubation of decapsulated testes with collagenase at 34" C followed by removal of seminiferous tubules from interstitial tissue webs. When examined by light microscopy, these isolated interstitial tissue webs were found to be essentially free of contaminating germ cells.y This method for isolation of interstitial tissue was used to obtain purified Leydig cells for studies of LH receptors and Leydig cell responsiveness to LH/ hCG. While evaluating different methods of purifying Leydig cells, we found evidence for the existence of two distinct populations of Leydig cells. Centrifugation of collagenase-dispersed cells from whole testes or from isolated interstitial tissue of mature rats in 640% Metrizamide gradients yielded two distinct peaks of Leydig cells, as identified by specific binding of [lZ51] hCG. One population (I) was found in fractions with a density of 1.085-1.117 g/cm" and the other population (11) was found in fractions with a density of 1.128-1.145 g/cm" (FIGURES 1 and 2 ) . A major peak of cells with a small amount of [lZ5I]hCG binding was found only in fractions with a density of 1.055-1.065 g/cm3 in gradients of dispersed cells from whole testes (FIGURE 1). The vast majority of cells in this peak are germ cells.
To assess if.Leydig cells found in peak I represented cells damaged by the collagenase treatment, cells representing peak I1 from a first Metrizamide gradient were combined, washed, and separated into two aliquots. One aliquot was subjected to a second treatment with collagenase under conditions identical to the original collagenase treatment, while the second aliquot was incubated in the same manner in the absence of collagenase. These aliquots of cells were then recentrifuged in separate Metrizamide gradients, and the distribution of Leydig cells in these gradients was determined by measuring specific binding of [1Z51]hCG in individual one-ml fractions. As seen in FIGURE 3, the second collagenase treatment did not result in a shift of Leydig cells from peak I1 to peak I, indicating that peak I Leydig cells are not damaged cells.
When fractions representing population I and population I1 Leydig cells were recentrifuged in Metrizamide gradients, the majority of Leydig cells (indicated by [1251] hCG binding) appeared in the same fractions as they had in the first gradient centrifugation.s These data indicate that the two populations of Leydig cells must differ as to size, shape, and/or density.
In order to improve the separation of populations I and I1 Leydig cells, a discontinuous gradient of Metrizamide has been used in our most recent studies. This gradient consists, from bottom to top, of 5 ml 27%, 10 ml 20%, and 10 ml 1 1 % Metrizamide dissolved in Medium 199 containing 0.1% BSA (bovine serum albumin). The percentages of Metrizamide used in the discontinuous gradient were based on those calculated from the refractive indices of As discussed below, population I may be further divided into two subpopulations of Leydig cells that differ in response to it2 vitro hCG stimulation.
These subpopulations are referred to as population IA (fractions [10] [11] [12] and population IB (fractions 13-15) . When fractions 10-12 (IA) and fractions 13-15 (IB) were recentrifuged in separate 0 to 40% continuous Metrizamide gradients, the [1221]hCG binding peak of population IA was found at fraction 19 and the peak Of population IB was found at fraction 21 (FIGURE 5 ) . Thus, population IB does not represent a mixture of populations IA and I1 Leydig cells as no Leydig cells were demonstrable by [12"J] hCG binding in fractions 25 to 29, the fractions that normally contain population I1 Leydig cells (FIGURES 1 and 2).
Identification of Leydig Cells
Leydig cells in each population were identified by histochemical staining for 3P-hydroxysteroid dehydrogenase as previously described.s Non-Leydig cells were identified by a counterstain with eosin. Cells were examined by light microscopy and total cells and cells containing dark purple formazan deposits were counted. Cells that stained purple, indicating the presence of 3F-hydroxysteroid dehydrogenase, were considered Leydig cells. From total cell counts obtained with a Coulter counter and from the percent Leydig cells obtained by staining, the number of Leydig cells in a sample was determined. This procedure allows us to express data per number of Leydig cells. Confirmation that only cells that stain positive for 3p-hydroxysteroid dehydrogenase specifically bind [lZ5I]hCG was obtained by autoradiography. Cells from fractions containing the two populations of Leydig cells were incubated with a saturating concentration of [1251] hCG alone and together with an excess of nonradioactive hCG, subjected to the histochemical reaction for 38-hydroxysteroid dehydrogenase, processed for autoradiography, and counterstained with eosin. Examination of slides by light microscopy indicated that all cells that were 3P-hydroxy-
Sedimentation profile of dispersed cells from isolated interstitial tissue of rat testes in a density gradient of 0-40% Metrizamide. Cells obtained by collagenase treatment of isolated interstitial tissue were layered on a Metrizamide gradient. After centrifugation for 5 min at 3300xg, 1-ml fractions were collected. Specific binding of [ISI] hCG (0-0) and the total number of cells (A --A) were determined in aliquots from the indicated 1-ml fraction. The bars (-) indicate the fractions combined from peaks I and 11, respectively for further purification in a second contained formazan deposits. Essentially no grains were associated with cells incubated with a n excess of unlabeled hCG (unpublished observations).
LH Receptor Sites
The number of L H / h C G receptor sites and the hCG-binding affinity were 
Leydig Cell Responsiveness
Responsiveness to hCG was determined in each population of Leydig cells, obtained from isolated interstitial tissue webs, using the same fractions that were used for the h C G binding studies. During a 3-h incubation in the absence of hCG, testosterone production (expressed as nanograms of testosterone per fmol of LH receptor sites) was similar in the two populations of Leydig cells. With increasing concentrations of hCG, population I Leydig cells responded with only a small increase in testosterone production. I n sharp contrast, testosterone production in population 11 Leydig cells was increased markedly in the presence of hCG, with maximal production observed at 3 pM hCG (FIGURE 7).s To determine whether the two populations of Leydig cells differed in their capacity to respond to dibutyryl cyclic AMP, cells were incubated with increasing concentrations of dibutyryl cyclic AMP (0.25-2 mM) (FIGURE 8).
As observed with hCG, testosterone production in population I1 Leydig cells was markedly greater than in population I Leydig cells.
Similar differences in testosterone production in response to increasing concentrations of hCG were observed during incubations of population I and population I1 Leydig cells obtained from whole testes after Metrizamide-gradient centrifugation. As seen with Leydig cells obtained from isolated interstitial tissue, the two populations exhibited similar concentrations of LH receptor sites per loG Leydig cells (FIGURE 9). Testosterone production in Leydig cell population I1 increased from 15 to 250 ng/lOG Leydig cells in the presence of hCG. In contrast, maximum testosterone production in population I was only 80 ng/ loF Leydig cells (FIGURE 9). Maximum production of testosterone was observed at similar concentrations of hCG in the two populations of Leydig cells. 
Eflects of LH ond hCG Treatment on Leydig Cell Responsiveness and LH Receptor Concentration
Twice-daily treatment with 6 or 12.5 p g LH for six days caused a marked increase in in vitro responsiveness of Leydig cell population I to hCG (FIGURE 10A). In contrast, only a small increase in testosterone production was seen in Leydig cell population I1 (FIGURE 10B). After six days of treatment, Leydig cell populations I and I1 produced similar amounts of testosterone in vitro in response to hCG. The change in in vitro responsiveness of Leydig cell population I after chronic in vivo LH treatment did not result in a change in sedimen- The effect of a single subcutaneous injection of 150 pg L H on in vitro testosterone production in response to hCG, 72 h later, is illustrated in FIGURE  11A . This dose, which is equal to the total amount that was administered in the twice-daily regimen of 12.5 pg for six days, resulted in losses of LH receptor sites of 57% and 79% in Leydig cell populations I and 11, respectively. This treatment had no effect on in vitro responsiveness to hCG in population I 0 0.5
Testosterone production of Leydig cells from each peak with increasing concentrations of dibutyryl cyclic AMP. Leydig cells from each peak (as described for FIGURE 7 ) were incubated for 3 h at 34" C with increasing concentrations of dibutyryl cyclic AMP. Testosterone (B) were incubated in duplicate as described in the legend to FIGURE 9. Each point represents the mean -t-SE of data from two separate experiments. Note the difference in the scales of the ordinates in A and B. The number in parentheses represents the percentage of LH receptor sites per 10' Leydig cells relative to A singIe subcutaneous injection of 100 I.U. of hCG completely desensitized all Leydig cells. Receptor loss was greater than 90% in both populations and was accompanied by complete loss of responsiveness t o in vitro hCG stirnulation 72 h after the injection of the hormone.10
These data demonstrate that the effect of LH or hCG on Leydig cell steroidogenesis is dependent on the mode of administration of the hormone and does not appear to relate to loss of LH receptor sites. Previous reports that have indicated that gonadotropin-induced loss of testicular LH receptors is accompanied by a decrease in in vitro LH/ hCG-stimulated testosterone production were based on studies using a single injection of hCG or LH.'. 4 f 6, Previous studies from our laboratory using mature male rats indicated that, although all variations of treatment with LH caused a loss of testicular LH receptors, only a single dose, 100 pg or greater, was accompanied by a decrease in in vivo testicular responsiveness to a subsequent stimulatory dose of LH. Injections of 15 pg LH. administered twice daily, for up to ten days resulted in a similar loss of testicular LH receptors as a single high dose of LH, but caused a timerelated increase in in vivo testicular resp0nsiveness.l Similar observations were made in mature hypophysectomized rats1 Thus, the present study as well as our previous studies clearly demonstrate that Leydig cell steroidogenic desensitization does not occur except after a single administration of a high, nonphysiological dose of LH or hCG. Since the testis is normally exposed to only small pulsatile LH discharges and not to massive LH surges, LH-induced steroidogenic desensitization as described by several authors 1* 4 , 6 , is not a likely mechanism by which Leydig cell steroid production is regulated in vivo. The demonstration that LH has different effects on the two populations of Leydig cells must be considered in future studies on hormonal regulation of Leydig cell function. At present, it is not known if chronic LH treatment also results in an increase in total numbers of Leydig cells as well as an increase in responFiveness of Leydig cell population I to acute LH/hCG stimulation.
Steroidogenic Eitzyrnes in Different Populations of Leydig Cells

Aromatase Activity
Considerable controversy has existed as to which cell type in the testis is the site of estrogen synthesis. Studies by Dorrington and colleagues l1 indicate that Sertoli cells from immature rats, when maintained in culture in the presence of follicle stimulating hormone (FSH) and testosterone, have the capacity to synthesize estradiol. i n more recent studies it was reported that treatment of adult or immature l:{ rats with LH or hCG resulted in induction of testicular aromatase activity. Administration of FSH to 15-day-old rats for 3-4 days l :~ or to mature rats for 6 days1' had no effect on testicular aromatase activity. These latter observations suggest that in rats 15 days or older, Leydig cells 4 h (FIGURE 14) .I4
These data demonstrate that Leydig cells have the capacity to aromatize testosterone to estradiol and that this capacity is specific for population I1 
Enzymes Involved in the Conversion of C,, to C,, Androgens
As discussed earlier, a pronounced difference in testosterone production was evident between the two populations of Leydig cells when cells were incubated with dibutyryl CAMP. This observation suggests that the difference in respon- (SER) of the rat Leydig cells,17 and a recent report has shown that species differences in testosterone production are correlated with SER volume and density.lV
In these enzyme studies, Leydig cells were separated by centrifugation in a discontinuous Metrizamide gradient as described earlier in this chapter. In preliminary experiments it was found that hCG-stimulated testosterone production in individual 1-ml fractions representing population I (fractions 10-1 5, FIGURE 3) was markedly higher in fractions 13-15 than in fractions 10-12. This finding suggested that fractions 10-12 and 13-15 may represent different subpopulations of Leydig cells. As noted earlier, fractions 13-15 were not a mixture of populations IA and 11. No difference in hCG-stimulated testosterone production was observed between individual 1 -ml fractions (fractions 20-24) representing population I1 Leydig cells (unpublished data). ID view of these findings, enzyme studies have been carried out using subpopulations IA and IB as well as population I1 Leydig cells. were collected from a discontinuous Metrizamide gradient and incubated for 3 h at 34" C in the presence of increasing concentrations of hCG. Testosterone concentration in cells and medium was measured by RIA. The mean t-SE of duplicate determination is shown. Analysis of variance (not including basal testosterone production)
showed that there was a significant (P < 0.001) difference between hCG-stimulated levels of testosterone production in populations IB and II.23
.T
Testosterone production in response to increasing concentrations of hCG in the three populations is shown in FIGURE 15. Population I1 Leydig cells produced significantly more testosterone than population IB, and both showed markedly higher production than population IA. In the presence of 30 pM hCG, testosterone production was stimulated 12-fold to 250 ng/ 10" Leydig cells in population 11, 10-fold to 180 ng/lOG Leydig cells in population IB, and 4.5-fold to 50 ng/lOG Leydig cells in population IA. L H receptor sites, expressed as fmol per lo6 Leydig cells, were similar in the three populations; 1 0 2 i 6 ( m e a n t S E , n = 5 ) , 1 0 8 e 15 ( t t = 5 ) , and 9 9 k 9 ( n = 5 ) in Leydig cell populations IA, IB, and 11, respectively.
In order to evaluate steroidogenic enzyme activities, dispersed testicular cells from whole testes of 60-day-old rats were separated by centrifugation in discontinuous Metrizamide gradients. Fractions 10-12, 13-1 5 , and 20-24 were combined as populations IA, IB, and 11, respectively. The saturating substrate concentration for each enzyme activity was established in preliminary studies. The activity of A5-3/3-hydroxysteroid dehydrogenase-isomerase was studied in cellular homogenates by measuring the conversion of [3H]pregnenolone to [3H]progesterone in the presence of 0.5 mM NAD+ during a 10-min incubation.'O Since [1251]hCG binding per lo6 Leydig cells was found to be essentially identical in all populations of Leydig cells, A5-3/3-hydroxysteroid dehydrogenase-isomerase activity was expressed as pmol progesterone produced per fmol [1261]hCG bound. No difference in the activity of this enzyme was observed between populations IA and IB, although both of these subpopulations showed markedly higher activity than population I1 (TABLE 1) .
The remainder of the enzyme activities were investigated in intact cell preparations. Cells were incubated for 1 h at 3 4°C with the appropriate 3H-labeled substrate. Steroids were extracted and separated as described previo~s l y .~~ The 17-hydroxylase activity was determined by measuring the conversion of progesterone to 17-hydroxyprogesterone, androstenedione, and 
I1
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testosterone. The 17-hydroxylase activity was twice as high in populations IB and I1 than in population IA (TABLE 2 ) . There was no difference in activity between populations IB and ILZ3 The C,,-C,, lyase activity was determined by measuring the conversion of 17-hydroxyprogesterone to androstenedione and testosterone. The C,,-C,, lyase activity in the three populations of Leydig cells is shown in TABLE 3. The activity of this enzyme was different in all three populations of Leydig cells. Both populations IB and I1 showed higher activity than population IA, population IB showing 2.45-fold higher activity and population I1 3.6-fold higher activity than population IA.'"
The 17-ketosteroid reductase activity was determined by measuring the conversion of androstenedione to testosterone and dihydrotestosterone. As shown in TABLE 4, this enzyme activity did not differ markedly between the three populations, although activity in population IA was slightly less than in populations IB and IL2%
These data demonstrate that there were distinct differences in the patterns of various steroidogenic enzyme activities among the three Leydig cell populations. The higher activity of A5-3/3-hydroxysteroid dehydrogenase-isomerase in populations IA and IB, compared to population 11, would suggest that this enzyme is not rate-limiting for androgen synthesis in the mature rat testis (at least in populations IA and IB) as testosterone production is highest in population 11. Of the enzyme activities measured, only C,,-C,, lyase showed a difference between all three populations of Leydig cells. Differences in the activity of this enzyme among the Leydig cell populations closely paralleled the differences in hCG-stimulated testosterone production shown in FIGURE 17.
This observation suggests that the lower testosterone production seen in populations IA and IB may be, at least partly, a consequence of decreased C,,-steroid production from 1 7-hydroxyprogesterone.
During sexual maturation of the male rat the appearance of 17-ketosteroid reductase activity closely parallels the ability of the testis to produce testosterone in vitro. 21 These results suggested that 17-ketosteroid reductase may be ratelimiting in the immature rat. From results reported here, however, it can bc seen that there is little difference in the activity of this enzyme among the three Leydig cell populations. This suggests that 17-ketosteroid reductase is not rate-limiting in the mature rat testis. Although no major differences in 17-ketosteroid reductase activity were observed in the populations of Leydig cells, it is interesting to note that the apparent Sa-reduction of testosterone to dihydrotestosterone shown in TABLE 4 is markedly higher in populations IA and IB than population 11. The activity of testicular Sa-reductase is at a maximum in 35-day-old rats and decreases markedly during sexual maturation.22 It is therefore possible that populations IA and IB represent "immature" Leydig cells which may differentiate during sexual maturation into population I1 Leydig cells. In an attempt to resolve this issue, we investigated changes in the relative number of Leydig cells in each population during sexual maturation. 
Developmental Changes in Distribution of Leydig Cells
Between Populations I and I1
Changes in the distribution of Leydig cells between populations I and I1
were evaluated during pubertal development. Decapsulated testes from rats between the ages of 38 and 55 days were completely dissociated by incubation for 25 min with collagenase (1 mg/ml) in medium containing 1.5 mg/ml BSA. To facilitate complete dissociation, the tissue was dispersed several times with pasteur pipettes during the incubation. Leydig cell populations I and I1 were separated by centrifugation in discontinuous gradients of Metrizamide. One-ml fractions were collected from the top of the gradient and specific binding of FIGURE 18. Binding of ['"IIhCG by population I and I1 Leydig cells from rats at various ages during puberty. Testes were completely dissociated as described in text, centrifuged in discontinuous Metrizamide gradients, and specific binding of ["7] hCG to cells of individual fractions was determined, as described in the legend to FIGURE 1. Values for fractions [11] [12] [13] [14] [15] [16] [17] and fractions 20-24 were totaled to obtain values for population I and population I1 Leydig cells, respectively. Values were normalized to represent one testis at each age.
Examination of Leydig Celk b y Electron Microscopy
Cells from completely dispersed testes were separated by centrifugation in discontinuous gradients of Metrizamide. One-ml fractions representing population I and population 11, as described in the preceding section, were combined, fixed in suspension, centrifuged to collect the pellet of cells, and processed for electron microscopy. Based on developmental studies of the type described above, two ages were chosen to represent the two basic patterns of distribution of Leydig cells between the two populations. Electron micrographs of Leydig cell populations I and I1 from 38-and from 54-day-old animals indicated that the Leydig cells were intact and displayed the morphological characteristics described for rat Leydig
As shown in FIGURES 19-22, these characteristics include abundant smooth endoplasmic reticulum, occasional patches of rough endoplasmic reticulum, mitochondria with lamellar cristae, a prominent Golgi apparatus, and a large ovoid nucleus with a thin rim of peripheral heterochromatin. Other common organelles include lysosomes, multivesicular bodies, and peroxisomes. Lipid droplets are also present but they are more numerous in Leydig cells from the immature animals (FIGURES 20-22) . Preliminary observations have not revealed any consistent differences in the morphology between the two populations a t either age. However, more detailed morphological analyses are presently under way to determine if structural differences exist between the two populations that could explain the observed differences in responsiveness, in enzyme activity, and in sedimentation in Metrizamide gradients. mentioned that the receptor number per cell in the two populations was not different as animals age. Was the receptor affinity different?
PAYNE: We've tested affinity only in the adults so far, so there is still a possibility that the affinity is different in young animals. DIAS: It would be worth checking because small differences in affinity could explain the differences in total binding that you saw between the two Leydig cell populations. T h e conclusion that you are drawing from the study is that there are different numbers of Leydig cells in the two populations.
PAYNE: It obviously has to be studied further. ROBAIRE: If the difference between population I and I1 is simply a question of the degree to which those cells are stimulated and the difference in sedimentation, simply a reflection of the amount of smooth ER, then you really don't have two populations but a continuum of populations. PAYNE: That is very possible. I think there could very well be a continuum of one population especially bands 1A and 1B.
ROBAIRE: The amount that you get of any cell depends entirely on the state of the animal, which wouid fit with your developmental data.
PAYNE: As I said, I don't know the factors that control this apparent change from population I to I1 and we certainly have to look into whether it's controlled by hormonal stimulation.
M. L. DUFAU (Nationnl Institutes of Health, Bethesda, M d . ) : Have YOU examined desensitization with these new conditions? PAYNE: We have not gone back and re-examined the effect of desensitization using the new gradient.
DUFAU: Therefore, it seems likely that your 1B population corresponds to our number 3 and 4 population and is likely to have the same desensitization as your 1 and 2.
PAYNE: That's very possihie. The major point I wish to emphasize in regard to desensitization is that the effect of exogenous LH on Leydig cell steroidogenesis depends upon whether steroidogenic response is examined after administration of a single, high dose of LH (which does not occur under any physiological or pathological conditions) or after multiple daily injections of LH.
There is also a difference between hCG, the latter has a much longer halflife than LH. I don't think we can say that hCG is comparable to what really occurs in vivo with LH.
V. HANSSON (Rikshospitdet, Oslo, Norway) : Drs. Purvis and Claussen in Oslo have looked at the correlation between L H receptor binding by autoradiography and 38-hydroxysteroid dehydrogenase (38-HSD) . Relow 20 days of age only 10-15% of Leydig cells actually show 3P-HSD reaction, which gradually increases to 100% around day 50, and then drops again after age 60. 3P-HSD activity alone may not demonstrate all the Leydig cells because you have a threshold for the enzymc activity. Population I1 only had half the 3P-HSD activity of population I. You could ask the question, do they have the same binding, or have you in population I1 only recorded half of the Leydig cells because of the threshold with your 3P-HSD cytochemistry?
PAYNE: I could not have looked at only half, because 90% of all the cells in population I1 stained positively. As far as binding per Leydig cell, after age 25 there certainly is a marked difference in binding per Leydig cell compared to animals that are younger. We are not looking at difference in intensity, we are looking at positive staining and comparing that to the binding. We don't see cells that concentrate grains that don't stain positive for 3P-hydroxy-steroid dehydrogenase.
M. ASCOLI (Vanderbilt University, Nashville, Tenn.) : How do you know whether population 1 B isn't 1 A and II?
PAYNE: We do believe population 1B is not a mixture of 1A and population I1 Leydig cells because we have recentrifuged population 1B in a 0 to 40% continuous gradient and couldn't demonstrate that. PAYNE: Yes, we have. In in vivo studies we have followed Leydig cell responses with twice-daily injections over a ten-day period, measured first at three days. There was a time-related increase in responsiveness over the ten day period; while with a single subcutaneous injection the maximum decrease in receptors and in responsiveness was observed between two and three days. The response increased after three days and returned to normal by five days. At 72 hours, we observe the maximum decrease in both LH receptor and testosterone concentration. B. A. COOKE (London University, London, England): I'd just like to interject a word of caution on the way we're preparing the cells and the way we're separating them. Using Metrizamide, which I have never been very happy with, it's possible to get damaged cells. Schumacher and Hilz have shown that Metrizamide will damage mouse Leydig cells. Leydig cell populations seem to be much higher than we would think using different media. Using different media we consistently get active Leydig cells in your band 11, at a density of about 1.07 and this is consistently lower than any of the other reported densities.
PAYNE: I'm only reporting the density of the Metrizamide solution where these Leydig cells are found and I don't know the density of these Leydig cells.
COOKE: Mechanical dispersion can completely destroy the steroidogenic potential of the Leydig cells, although they still have LH receptors. We've recently been using Percoll to separate mouse Leydig cells and get a very distinct band of responsive cells. Within that band we find some heterogeneity but they don't separate out into two distinct populations. Rather there's a whole range of activities described by 3/3-dehydrogenase in response to LH. From rats using Percoll, we also get two populations, but again it seems as if it is a whole range of activities rather than two distinct populations.
PAYNE: It could be a range but I still feel that populations I1 and I are different. Population I is sort of a range of different types of Leydig cells. Obviously we have to do more studies to get this all sorted out.
T. LIN (University of South CaroZina, Columbia, S.C.) : Recently we also found two distinct populations of Leydig cells in 24-month-old rats. Interestingly, both populations respond to LH stimulation with increased cyclic AMP production, but only population I1 may have increased testosterone production. A. RIVENSON (American Health Foundation, Valhalla, N . Y . ) : Dr. Dehejia mentioned that lymphocytes are occasionally attached to Leydig cells. Lymphocytes actually attach to Leydig cells as a rule. If we combine suspensions of Leydig cells and lymphocytes, B-lymphocytes or T-lymphocytes, we obtain beautifully formed rosettes. The only requirement is not to use enzymes to disperse the Leydig cells because we remove the receptors from the membrane. We can separate two populations of Leydig cells, one population forming rosettes, that means having receptors for lymphocytes and another smaller population not having this type of receptors.
PAYNE: To protect against destruction of receptors, we've been adding 1.5% BSA. If you use concentrations of collagenase higher than 0.25 milligrams per ml you start seeing destruction of L H receptor sites. There is a difference in sensitivity in the two populations.
